Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 BMO Capital...

* Reuters is not responsible for the content in this press release.

Tue Aug 5, 2008 9:43am EDT 

Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 BMO Capital Markets Focus on Healthcare Conference

CAMBRIDGE, Mass.--(Business Wire)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced
that it will webcast its corporate presentation at the 2008 BMO
Capital Markets Focus on Healthcare Conference on Wednesday, August 6,
2008 at 9:00 a.m. EDT.

   The presentation will be webcast live and may be accessed from
'Events & Presentations' on the home page of Vertex's website at
www.vrtx.com. A replay of the webcast will also be available on the
Company's website for two weeks following the presentation. To ensure
a timely connection, it is recommended that users register at least 15
minutes prior to the scheduled webcast.

   About Vertex

   Vertex Pharmaceuticals Incorporated is a global biotechnology
company committed to the discovery and development of breakthrough
small molecule drugs for serious diseases. The Company's strategy is
to commercialize its products both independently and in collaboration
with major pharmaceutical companies. Vertex's product pipeline is
focused on viral diseases, inflammation, autoimmune diseases, cancer,
pain and cystic fibrosis. Vertex co-discovered the HIV protease
inhibitor, Lexiva, with GlaxoSmithKline.

   Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.

   Vertex's press releases are available at www.vrtx.com.

   (VRTX-WEB)

Vertex Pharmaceuticals Incorporated
Lora Pike, 617-444-6755
Manager, Investor Relations

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.